Search research articles
Contact Us
Filters
Showing results (11-20 of 120) with videos related to
Page
of 12
Sort By:
Urology
|
July 5, 2005
Reduction of pulmonary migration of permanent interstitial sources in patients undergoing prostate brachytherapy
Nelson N Stone, Richard G Stock
Urology
|
December 4, 2020
EDITORIAL COMMENT
Nelson N Stone, E David Crawford
European Urology
|
June 21, 2002
Importance of post-implant dosimetry in permanent prostate brachytherapy
Richard G Stock, Nelson N Stone
The Journal of Urology
|
February 14, 2007
The effect of brachytherapy, external beam irradiation and hormonal therapy on prostate volume
Nelson N Stone, Richard G Stock
Brachytherapy
|
February 7, 2013
Prostate brachytherapy in men with gland volume of 100cc or greater: Technique, cancer control, and morbidity
Nelson N Stone, Richard G Stock
Brachytherapy
|
December 19, 2013
Does dose matter? Editorial comments to Morris et al. Whole prostate D90 and V100: a dose-response analysis of 2000 consecutive (125)I monotherapy cases
Nelson N Stone, Richard G Stock
BJU International
|
June 30, 2018
Stage T3b prostate cancer diagnosed by seminal vesicle biopsy and treated with neoadjuvant hormone therapy, permanent brachytherapy and external beam radiotherapy
Nelson N Stone, Richard G Stock
Brachytherapy
|
April 6, 2004
Prospective assessment of patient-reported long-term urinary morbidity and associated quality of life changes after 125I prostate brachytherapy
Nelson N Stone, Richard G Stock
Brachytherapy
|
April 6, 2004
Preliminary toxicity and prostate-specific antigen response of a Phase I/II trial of neoadjuvant hormonal therapy, 103Pd brachytherapy, and three-dimensional conformal external beam irradiation in the treatment of locally advanced prostate cancer
Richard G Stock, Nelson N Stone
Urology
|
February 27, 2007
Long-term urinary, sexual, and rectal morbidity in patients treated with iodine-125 prostate brachytherapy followed up for a minimum of 5 years
Nelson N Stone, Richard G Stock
Page
of 12
Search research articles
Search
Showing results (11-20 of 120) with videos related to
Sort By:
Page
of 12
Urology
|
July 5, 2005
Reduction of pulmonary migration of permanent interstitial sources in patients undergoing prostate brachytherapy
Nelson N Stone, Richard G Stock
Urology
|
December 4, 2020
EDITORIAL COMMENT
Nelson N Stone, E David Crawford
European Urology
|
June 21, 2002
Importance of post-implant dosimetry in permanent prostate brachytherapy
Richard G Stock, Nelson N Stone
The Journal of Urology
|
February 14, 2007
The effect of brachytherapy, external beam irradiation and hormonal therapy on prostate volume
Nelson N Stone, Richard G Stock
Brachytherapy
|
February 7, 2013
Prostate brachytherapy in men with gland volume of 100cc or greater: Technique, cancer control, and morbidity
Nelson N Stone, Richard G Stock
Brachytherapy
|
December 19, 2013
Does dose matter? Editorial comments to Morris et al. Whole prostate D90 and V100: a dose-response analysis of 2000 consecutive (125)I monotherapy cases
Nelson N Stone, Richard G Stock
BJU International
|
June 30, 2018
Stage T3b prostate cancer diagnosed by seminal vesicle biopsy and treated with neoadjuvant hormone therapy, permanent brachytherapy and external beam radiotherapy
Nelson N Stone, Richard G Stock
Brachytherapy
|
April 6, 2004
Prospective assessment of patient-reported long-term urinary morbidity and associated quality of life changes after 125I prostate brachytherapy
Nelson N Stone, Richard G Stock
Brachytherapy
|
April 6, 2004
Preliminary toxicity and prostate-specific antigen response of a Phase I/II trial of neoadjuvant hormonal therapy, 103Pd brachytherapy, and three-dimensional conformal external beam irradiation in the treatment of locally advanced prostate cancer
Richard G Stock, Nelson N Stone
Urology
|
February 27, 2007
Long-term urinary, sexual, and rectal morbidity in patients treated with iodine-125 prostate brachytherapy followed up for a minimum of 5 years
Nelson N Stone, Richard G Stock
Page
of 12